Unigestion Holding’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-935
Closed -$462K 205
2023
Q2
$462K Sell
935
-2,932
-76% -$1.41M 0.03% 181
2023
Q1
$1.91M Buy
3,867
+4
+0.1% +$1.91K 0.1% 108
2022
Q4
$1.59M Hold
3,863
0.08% 124
2022
Q3
$1.28M Hold
3,863
0.07% 126
2022
Q2
$1.35M Sell
3,863
-239
-6% -$97.5K 0.08% 119
2022
Q1
$2.25M Sell
4,102
-134
-3% -$70.5K 0.1% 88
2021
Q4
$2.79M Buy
4,236
+1,865
+79% +$1.17M 0.11% 85
2021
Q3
$1.47M Sell
2,371
-1,326
-36% -$891K 0.06% 104
2021
Q2
$2.36M Sell
3,697
-1,211
-25% -$669K 0.08% 96
2021
Q1
$2.4M Buy
+4,908
New +$2.46M 0.09% 93

Other funds holding IDXX

Unigestion Holding's IDXX Position: Q3 2023 in Review

Unigestion Holding sold out of Idexx Laboratories (IDXX) in Q3 2023, closing a stake of 935 shares — an estimated $462K sold.

Unigestion Holding first reported a position in IDXX in Q1 2021 and held it in 10 quarters. The position peaked at $2.79M in Q4 2021. 1,059 funds tracked by Wall St. Rank hold IDXX as of Q3 2023.

  • Unigestion Holding reported no remaining Idexx Laboratories position as of Q3 2023 after selling out during the quarter.
  • Unigestion Holding sold 935 Idexx Laboratories shares in Q3 2023, an estimated $462K.
  • Unigestion Holding first reported a position in Idexx Laboratories in Q1 2021 and held it in 10 quarters.
  • Unigestion Holding's Idexx Laboratories position peaked at $2.79M in Q4 2021.
  • 1,059 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2023.

Based on Unigestion Holding's 13F filing for Q3 2023, filed 31 Oct 2023.